Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 301575, 9 pages
http://dx.doi.org/10.1155/2014/301575
Review Article

The Role of Wnt Signaling in the Development of Alzheimer’s Disease: A Potential Therapeutic Target?

1Geriatrics Department of Traditional Chinese Medicine, Huadong Hospital, Fudan University, Shanghai 200040, China
2Shanghai Institute of Geriatrics, Huadong Hospital, Fudan University, Shanghai 200040, China
3Department of Perinatal Medicine Pregnancy Research Centre and University of Melbourne Department of Obstetrics and Gynaecology, Royal Women’s Hospital, Parkville, VIC 3052, Australia

Received 12 October 2013; Accepted 10 April 2014; Published 4 May 2014

Academic Editor: Raymond Chuen-Chung Chang

Copyright © 2014 Wenbin Wan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [34 citations]

The following is the list of published articles that have cited the current article.

  • Chia-Chen Liu, Chih-Wei Tsai, Ferenc Deak, Justin Rogers, Michael Penuliar, You Me Sung, James N. Maher, Yuan Fu, Xia Li, Huaxi Xu, Steven Estus, Hyang-Sook Hoe, John D. Fryer, Takahisa Kanekiyo, and Guojun Bu, “Deficiency in LRP6-Mediated Wnt Signaling Contributes to Synaptic Abnormalities and Amyloid Pathology in Alzheimer’s Disease,” Neuron, 2014. View at Publisher · View at Google Scholar
  • Yves Lecarpentier, Victor Claes, Guillaume Duthoit, and Jean-Louis Hébert, “Circadian rhythms, Wnt/beta-catenin pathway and PPAR alpha/gamma profiles in diseases with primary or secondary cardiac dysfunction,” Frontiers in Physiology, vol. 5, 2014. View at Publisher · View at Google Scholar
  • Hong Yue, Feng Lu, Chen Shen, and Jun-Min Quan, “Structure-based design of benzo[e]isoindole-1,3-dione derivatives as selective GSK-3 beta inhibitors to activate Wnt/beta-catenin pathway,” Bioorganic Chemistry, vol. 61, pp. 21–27, 2015. View at Publisher · View at Google Scholar
  • Zhiming Cui, Li Zhou, Yan Song, Chun Liu, Guanghui Zhu, Xinmin Wu, Yaohua Yan, Xiaopeng Xia, Chengwei Duan, Ying Zhou, Yuejiao Huang, and Dongmei Zhang, “Up-Regulation of Corticocerebral NKD2 in Lipopolysaccharide-Induced Neuroinflammation,” Cellular and Molecular Neurobiology, 2015. View at Publisher · View at Google Scholar
  • Marc-Antoine Lauzon, Alex Daviau, Bernard Marcos, and Nathalie Faucheux, “Growth factor treatment to overcome Alzheimer's dysfunctional signaling,” Cellular Signalling, 2015. View at Publisher · View at Google Scholar
  • Shah, Sohrabi, Verdile, Martins, Goozee, Rainey-Smith, and Brown, “Examining the potential clinical value of curcumin in the prevention and diagnosis of Alzheimer's disease,” British Journal of Nutrition, vol. 115, no. 3, pp. 449–465, 2015. View at Publisher · View at Google Scholar
  • Ameneh Zare-shahabadi, Eliezer Masliah, Gail V.W. Johnson, and Nima Rezaei, “Autophagy in Alzheimer’s disease,” Reviews in the Neurosciences, vol. 26, no. 4, 2015. View at Publisher · View at Google Scholar
  • Wenbin Wan, Lan Cao, Bill Kalionis, Shijin Xia, and Xiantao Tai, “Applications of Induced Pluripotent Stem Cells in Studying the Neurodegenerative Diseases,” Stem Cells International, vol. 2015, pp. 1–11, 2015. View at Publisher · View at Google Scholar
  • Xuan Cheng, Lu Zhang, and Ya-Jun Lian, “Molecular Targets in Alzheimer’s Disease: From Pathogenesis to Therapeutics,” BioMed Research International, vol. 2015, pp. 1–6, 2015. View at Publisher · View at Google Scholar
  • Yu Zhang, Long-Jian Huang, Si Shi, Shao-Feng Xu, Xiao-Liang Wang, and Ying Peng, “L-3-n-butylphthalide Rescues Hippocampal Synaptic Failure and Attenuates Neuropathology in Aged APP/PS1 Mouse Model of Alzheimer's Disease,” CNS Neuroscience & Therapeutics, 2016. View at Publisher · View at Google Scholar
  • Patricia Martorell, Silvia Llopis, Nuria Gonzalez, Daniel Ramón, Gabriel Serrano, Ana Torrens, Juan M. Serrano, Maria Navarro, and Salvador Genovés, “ A nutritional supplement containing lactoferrin stimulates the immune system, extends lifespan, and reduces amyloid β peptide toxicity in Caenorhabditis elegans ,” Food Science & Nutrition, vol. 5, no. 2, pp. 255–265, 2016. View at Publisher · View at Google Scholar
  • Yuanwei Yan, Julie Bejoy, Junfei Xia, Jingjiao Guan, Yi Zhou, and Yan Li, “Neural Patterning of Human Induced Pluripotent Stem Cells in 3-D Cultures for Studying Biomolecule-directed Differential Cellular Responses,” Acta Biomaterialia, 2016. View at Publisher · View at Google Scholar
  • Sudha Warrier, Raja Marimuthu, Sreeja Sekhar, G. Bhuvanalakshmi, Frank Arfuso, Anjan Kumar Das, Ramesh Bhonde, Ralph Martins, and Arun Dharmarajan, “sFRP-mediated Wnt sequestration as a potential therapeutic target for Alzheimer’s disease,” The International Journal of Biochemistry & Cell Biology, 2016. View at Publisher · View at Google Scholar
  • Cheril Tapia-Rojas, Patricia V. Burgos, and Nibaldo C. Inestrosa, “Inhibition of Wnt signaling induces amyloidogenic processing of amyloid precursor protein and the production and aggregation of Amyloid-β (Aβ)42 peptides,” Journal of Neurochemistry, vol. 139, no. 6, pp. 1175–1191, 2016. View at Publisher · View at Google Scholar
  • Annalucia Serafino, Gianluca Sferrazza, Arianna Colini Baldeschi, Giuseppe Nicotera, Federica Andreola, Eugenia Pittaluga, and Pasquale Pierimarchi, “Developing drugs that target the Wnt pathway: recent approaches in cancer and neurodegenerative diseases,” Expert Opinion on Drug Discovery, vol. 12, no. 2, pp. 169–186, 2016. View at Publisher · View at Google Scholar
  • Alexandre Vallée, and Yves Lecarpentier, “Alzheimer Disease: Crosstalk between the Canonical Wnt/Beta-Catenin Pathway and PPARs Alpha and Gamma,” Frontiers in Neuroscience, vol. 10, 2016. View at Publisher · View at Google Scholar
  • Savvas Thysiadis, Spyros Mpousis, Nicolaos Avramidis, Sotirios Katsamakas, Athanasios Balomenos, Rosaria Remelli, Spyros Efthimiopoulos, and Vasiliki Sarli, “Discovery of Novel Phenoxazinone Derivatives as DKK1/LRP6 Interaction Inhibitors: Synthesis, Biological evaluation and Structure-Activity Relationships,” Bioorganic & Medicinal Chemistry, 2016. View at Publisher · View at Google Scholar
  • Danièlle Gunn-Moore, Oksana Kaidanovich-Beilin, María Carolina Gallego Iradi, Frank Gunn-Moore, and Simon Lovestone, “Alzheimer's disease in humans and other animals—A consequence of postreproductive life span and longevity rather than aging,” Alzheimer's & Dementia, 2017. View at Publisher · View at Google Scholar
  • Airong Li, Rudolph E. Tanzi, Basavaraj Hooli, Kristina Mullin, Rebecca E. Tate, Adele Bubnys, Rory Kirchner, Brad Chapman, Oliver Hofmann, and Winston Hide, “Silencing of the Drosophila ortholog of SOX5 leads to abnormal neuronal development and behavioral impairment,” Human Molecular Genetics, vol. 26, no. 8, pp. 1472–1482, 2017. View at Publisher · View at Google Scholar
  • Na Jin, Huazhang Zhu, Jiazuan Ni, Xiao Liang, Wei Huang, Qingguo Xie, Peng Xiao, and Qiong Liu, “Sodium selenate activated Wnt/β-catenin signaling and repressed amyloid-β formation in a triple transgenic mouse model of Alzheimer's disease,” Experimental Neurology, vol. 297, pp. 36–49, 2017. View at Publisher · View at Google Scholar
  • Alexandre Vallée, Yves Lecarpentier, Rémy Guillevin, and Jean-Noël Vallée, “Reprogramming energetic metabolism in Alzheimer's disease,” Life Sciences, 2017. View at Publisher · View at Google Scholar
  • Alexandre Vallée, Yves Lecarpentier, Rémy Guillevin, and Jean-Noël Vallée, “Effects of cannabidiol interactions with Wnt/β-catenin pathway and PPARγ on oxidative stress and neuroinflammation in Alzheimer's disease,” Acta Biochimica et Biophysica Sinica, vol. 49, no. 10, pp. 853–866, 2017. View at Publisher · View at Google Scholar
  • Jing Ma, Yi Zhang, Yan-Min Luo, Qian Xiao, Hua-Rong Yu, Rong Jiang, Yong Tang, Yuan Gao, Lin Jiang, Feng-Lei Chao, Wei Huang, Chun-Ni Zhou, Wei Tang, Lei Zhang, and Chun-Xia Huang, “Fluoxetine attenuates the impairment of spatial learning ability and prevents neuron loss in middle-aged APPswe/PSEN1dE9 double transgenic Alzheimer's disease mice,” Oncotarget, vol. 8, no. 17, pp. 27676–27692, 2017. View at Publisher · View at Google Scholar
  • Daniel W. Nixon, “The inverse relationship between cancer and Alzheimer's disease: A possible mechanism,” Current Alzheimer Research, vol. 14, no. 8, pp. 883–893, 2017. View at Publisher · View at Google Scholar
  • Raffaella Nativio, Jon B. Toledo, Sager J. Gosai, Brian D. Gregory, Claudio Torres, F. Brad Johnson, Greg Donahue, Amit Berson, Yemin Lan, Ferit Tuzer, John Q. Trojanowski, Li-San Wang, Nancy M. Bonini, Shelley L. Berger, and Alexandre Amlie-Wolf, “Dysregulation of the epigenetic landscape of normal aging in Alzheimer's disease,” Nature Neuroscience, vol. 21, no. 4, pp. 497–505, 2018. View at Publisher · View at Google Scholar
  • Jörg Wilting, and Jürgen Becker, “WNT signaling, the development of the sympathoadrenal–paraganglionic system and neuroblastoma,” Cellular and Molecular Life Sciences, vol. 75, no. 6, pp. 1057–1070, 2018. View at Publisher · View at Google Scholar
  • Alexandre Vallée, Yves Lecarpentier, Rémy Guillevin, and Jean-Noël Vallée, “Thermodynamics in Neurodegenerative Diseases: Interplay Between Canonical WNT/Beta-Catenin Pathway–PPAR Gamma, Energy Metabolism and Circadian Rhythms,” NeuroMolecular Medicine, 2018. View at Publisher · View at Google Scholar
  • Daniel Nixon, “Down Syndrome, Obesity, Alzheimer’s Disease, and Cancer: A Brief Review and Hypothesis,” Brain Sciences, vol. 8, no. 4, pp. 53, 2018. View at Publisher · View at Google Scholar
  • Rafaela Peron, Izabela Vatanabe, Patricia Manzine, Antoni Camins, and Márcia Cominetti, “Alpha-Secretase ADAM10 Regulation: Insights into Alzheimer’s Disease Treatment,” Pharmaceuticals, vol. 11, no. 1, pp. 12, 2018. View at Publisher · View at Google Scholar
  • Cheril Tapia-Rojas, and Nibaldo C. Inestrosa, “Wnt signaling loss accelerates the appearance of neuropathological hallmarks of Alzheimer's disease in J20-APP transgenic and wild-type mice,” Journal of Neurochemistry, 2018. View at Publisher · View at Google Scholar
  • Amira A. El-Gazar, Ayman A. Soubh, Eman A. Mohamed, Azza S. Awad, and Hanan S. El-Abhar, “Morin post-treatment confers neuroprotection in a novel rat model of mild repetitive traumatic brain injury by targeting dementia markers, APOE, autophagy and Wnt/β-catenin signaling pathway,” Brain Research, vol. 1717, pp. 104–116, 2019. View at Publisher · View at Google Scholar
  • Nicholas G. Norwitz, Adrian Soto Mota, Sam G. Norwitz, and Kieran Clarke, “Multi-Loop Model of Alzheimer Disease: An Integrated Perspective on the Wnt/GSK3β, α-Synuclein, and Type 3 Diabetes Hypotheses,” Frontiers in Aging Neuroscience, vol. 11, 2019. View at Publisher · View at Google Scholar
  • Simone Granno, Jonathon Nixon-Abell, Daniel C. Berwick, Justin Tosh, George Heaton, Sultan Almudimeegh, Zenisha Nagda, Jean-Christophe Rain, Manuela Zanda, Vincent Plagnol, Victor L. J. Tybulewicz, Karen Cleverley, Frances K. Wiseman, Elizabeth M. C. Fisher, and Kirsten Harvey, “Downregulated Wnt/β-catenin signalling in the Down syndrome hippocampus,” Scientific Reports, vol. 9, no. 1, 2019. View at Publisher · View at Google Scholar
  • Haitham Amal, Guanyu Gong, Elizabeta Gjoneska, Sarah M. Lewis, John S. Wishnok, Li-Huei Tsai, and Steven R. Tannenbaum, “S-nitrosylation of E3 ubiquitin-protein ligase RNF213 alters non-canonical Wnt/Ca+2 signaling in the P301S mouse model of tauopathy,” Translational Psychiatry, vol. 9, no. 1, 2019. View at Publisher · View at Google Scholar